After the publication of our December 2007 supplement, “Health-related Quality of Life in Rheumatoid Arthritis,” the Editors learned that several authors were not given the opportunity to review the final proofs of their manuscripts. As a result, the following errors were subsequently identified. First, the co-author’s name was inadvertently omitted from the Introduction. The correct byline for the Introduction should read: Daniel E. Furst, MD, and Dinesh Khanna, MD.
Second, in the article “Generic Quality-of-life Assessment in Rheumatoid Arthritis,” by Tugwell, et al (Am J Manag Care. 2007;13[suppl 9]:S224-S236), some of the indicators for Health Dimension and Psychometric Properties were missing from Table 1; some data in Table 3 were incorrect; and the reference numbers in Figures 1a and 1b were misnumbered. The corrected tables and figures appear on the following pages (see pages 235-238).
Finally, due to the extent of the errors in the article by Strand et al, “Improved Health-related Quality of Life With Effective Disease-modifying Antirheumatic Drugs: Evidence From Randomized Controlled Trials,” we are reprinting a corrected version of this article in this issue (see pages 239-253).

From MSSP ACOs to Employer Value: Translating Value-Based Principles to Self-Insured Plans
December 12th 2025Value-based care adoption in employer insurance requires replacing fragmented point solutions with unified, at-risk performance contracts that align vendors, providers, and members around total cost and quality goals.
Read More
Legal Issues in Value-Based Care Contracts for Self-Insured Employers
December 12th 2025Self-insured employers face regulatory challenges when adopting value-based contracts, requiring careful data governance, standardized metrics, and legal frameworks to align with federal value-based care models.
Read More
From Complexity to Clarity: A Path to Value in Employer Health Plans
December 12th 2025Employers struggle to define value from health care spending amid complexity and misaligned incentives. Achieving measurable outcomes requires transparency, incentive realignment, and gradual, employee-centered change.
Read More
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
December 11th 2025Experts at a roundtable in Boston, Massachusetts, on November 3, 2025, discussed improving early Alzheimer disease diagnosis, addressing workforce and equity gaps, and expanding access to new disease-modifying therapies.
Read More